Search
  1. Home
  2. Africa

Roche cuts AIDS drugs costs

    JOHANNESBURG

    Drug manufacturing giant, Roche Pharmaceuticals on Tuesday announced further reductions in prices of its HIV protease inhibitors, Invirase and Viracept, for people living with HIV/AIDS in low and middle income countries.

    Roche said the price changes were effective immediately and terms and conditions of supply remain unchanged.

    William Burns, the head of Roche Pharmaceuticals, said in a statement that the company's action demonstrated its long term commitment to people living with HIV/AIDS in developing countries.

    "Until a cure for HIV/AIDS is discovered, research, prevention and treatment remain the key global priorities ... Roche is constantly reviewing its activities and is running a range of programmes on the ground for those living in the poorest countries," Burns said.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join